In addition to enhanced T cell activation and proliferation, the bispecific induced an antigen-specific memory T cell response, as shown by rejection of multiple tumor rechallenge inoculations in anti-PD-1–GITR-L-treated CT26 regressors (Fig. 6f). Here, DDX53 is linked to neoplasm.